Clinical trial
Asthma Intervention Research 2 (AIR2) Trial
NCT00231114 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00231114 |
|---|---|
| Title | Asthma Intervention Research 2 (AIR2) Trial |
| Official title | Safety and Effectiveness of the Alair® System for the Treatment of Asthma: A Multicenter Randomized Clinical Trial(Asthma Intervention Research (AIR2) Trial) |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Device |
| Interventions | Alair System |
| Enrollment | 297 |
| Start date | Sep 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Apr 1, 2013 |
| First posted | Oct 4, 2005 |
| Last update posted | Jul 27, 2017 |
| Countries | Australia, Brazil, Canada, Denmark, Netherlands, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: